US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.

Krishnan, Sonya; Chaisson, Richard E

Krishnan, Sonya; Chaisson, Richard E.

Afiliação

Krishnan S; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Chaisson RE; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Clin Infect Dis ; 78(3): 514-517, 2024 03 20.

Article em En | MEDLINE | ID: mdl-37879092

RESUMO

The provision of tuberculosis-preventive therapy (TPT) to vulnerable populations is critical for global control. Shorter-course TPT regimens are highly effective and improve completion rates. Despite incorporation of 1 month of rifapentine and isoniazid into global guidelines, current US TPT guidelines do not include this as a recommended regimen, but should.

Assuntos

Tuberculose Latente; Tuberculose; Humanos; Isoniazida/uso terapêutico; Antibioticoprofilaxia; Tuberculose/tratamento farmacológico; Tuberculose/prevenção & controle; Antituberculosos/uso terapêutico; Quimioterapia Combinada; Tuberculose Latente/tratamento farmacológico

Palavras-chave

1 month rifapentine and isoniazid; 1HP; tuberculosis infection; tuberculosis preventive therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Latente Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google